Nature Communications,
Journal Year:
2019,
Volume and Issue:
10(1)
Published: Sept. 12, 2019
Abstract
Astroglia
play
active
and
diverse
roles
in
modulating
neuronal/synaptic
functions
the
CNS.
How
these
astroglial
are
regulated,
especially
by
neuronal
signals,
remains
largely
unknown.
Exosomes,
a
major
type
of
extracellular
vesicles
(EVs)
that
originate
from
endosomal
intraluminal
(ILVs),
have
emerged
as
new
intercellular
communication
process.
By
generating
cell-type-specific
ILVs/exosome
reporter
(CD63-GFP
f/f
)
mice
immuno-EM/confocal
image
analysis,
we
found
CD63-GFP
+
ILVs
primarily
localized
soma
dendrites,
but
not
axonal
terminals
vitro
vivo.
Secreted
exosomes
contain
subset
microRNAs
(miRs)
is
distinct
miR
profile
neurons.
These
miRs,
neuron-specific
miR-124-3p,
potentially
internalized
into
astrocytes.
MiR-124-3p
further
up-regulates
predominant
glutamate
transporter
GLT1
suppressing
GLT1-inhibiting
miRs.
Our
findings
suggest
previously
undescribed
exosomal
miR-mediated
genetic
regulation
astrocyte
functions,
opening
frontier
understanding
CNS
communication.
Molecular Cancer,
Journal Year:
2020,
Volume and Issue:
19(1)
Published: Jan. 4, 2020
Abstract
Hepatocellular
carcinoma
(HCC)
is
the
most
commonmalignancy.
Exsome
plays
a
significant
role
in
elucidation
of
signal
transduction
pathways
between
hepatoma
cells,
angiogenesis
and
early
diagnosis
HCC.
Exosomes
are
small
vesicular
structures
that
mediate
interaction
different
types
contain
variety
components
(including
DNA,
RNA,
proteins).
Numerous
studies
have
shown
these
substances
exosomes
involved
growth,
metastasis
liver
cancer,
then
inhibited
growth
cancer
by
blocking
signaling
pathway
cells.
In
addition,
exosomal
could
also
be
used
as
markers
for
screening
cancer.
this
review,
we
summarized
to
reveal
significance
occurrence,
development,
treatment
HCC,
which
turn
might
help
us
further
elucidate
mechanism
promote
use
clinical
Brain,
Journal Year:
2020,
Volume and Issue:
143(5), P. 1476 - 1497
Published: March 15, 2020
Abstract
Accumulation
of
neuronal
α-synuclein
is
a
prominent
feature
in
Parkinson’s
disease.
More
recently,
such
abnormal
protein
aggregation
has
been
reported
to
spread
from
cell
and
exosomes
are
considered
as
important
mediators.
The
focus
research,
however,
primarily
neurons.
Given
the
increasing
recognition
importance
non-cell
autonomous-mediated
neurotoxicity,
it
critical
investigate
contribution
glia
spread.
Microglia
primary
phagocytes
brain
have
well-documented
inducers
neuroinflammation.
How
what
extent
microglia
their
impact
pathology
not
well
delineated.
We
report
here
that
when
treated
with
human
preformed
fibrils,
containing
released
by
fully
capable
inducing
recipient
Additionally,
combined
microglial
proinflammatory
cytokines,
these
further
increased
Inhibition
exosome
synthesis
reduced
transmission.
vivo
significance
was
demonstrated
stereotaxic
injection
isolated
fibrils
into
mouse
striatum.
Phosphorylated
observed
multiple
regions
consistent
connectivity.
These
animals
also
exhibited
neurodegeneration
nigrostriatal
pathway
time-dependent
manner.
Depleting
dramatically
suppressed
transmission
after
fibrils.
Mechanistically,
we
impaired
autophagy
flux
upregulating
PELI1,
which
turn,
resulted
degradation
LAMP2
activated
microglia.
importantly,
purifying
microglia/macrophage
derived
CSF
disease
patients,
confirmed
presence
oligomer
CD11b+
exosomes,
were
able
induce
neurons,
supporting
translational
aspect
this
study.
Taken
together,
our
study
supports
view
contribute
progression
therefore,
they
may
serve
promising
therapeutic
target
for
The FASEB Journal,
Journal Year:
2017,
Volume and Issue:
32(1), P. 512 - 528
Published: Sept. 21, 2017
Neuronal
inflammation
is
the
characteristic
pathologic
change
of
acute
neurologic
impairment
and
chronic
traumatic
encephalopathy
after
brain
injury
(TBI).
Inhibiting
excessive
inflammatory
response
essential
for
improving
outcome.
To
clarify
regulatory
mechanism
microglial
exosomes
on
neu-ronal
in
TBI,
we
focused
studying
impact
exosomal
miRNAs
injured
neurons
this
research.
We
used
a
repetitive
(r)TBI
mouse
model
harvested
extracts
from
to
phase
TBI
treat
cultured
BV2
microglia
vitro.
The
were
collected
miRNA
microarray
analysis,
which
showed
that
expression
level
miR-124-3p
increased
most
apparently
miRNAs.
found
promoted
anti-inflamed
M2
polarization
microglia,
inhibited
neuronal
scratch-injured
neurons.
Further,
mammalian
target
rapamycin
(mTOR)
signaling
was
implicated
as
being
involved
regulation
by
Gene
Ontology
Kyoto
Encyclopedia
Genes
Genomes
pathway
analyses.
Using
mTOR
activator
MHY1485
confirmed
inhibitory
effect
exerted
suppressing
activity
signaling.
PDE4B
predicted
be
gene
analysis.
proved
it
directly
targeted
with
luciferase
reporter
assay.
overexpressed
lentivirus
transfection
system,
suggested
suppressed
mainly
through
inhibiting
PDE4B.
In
addition,
neurite
outgrowth
scratch
injury,
characterized
an
increase
number
branches
total
length,
decreasedexpressiononRhoAand
neurodegenerative
proteins
[Aß-peptide
p-Tau].
It
also
improved
outcome
neuro-inflammation
mice
rTBI.
Taken
together,
can
inhibit
contribute
via
their
transfer
into
these
effects
targeting
PDE4B,
thus
Therefore,
could
promising
therapeutic
interventions
TBI.
manipulated
may
provide
novel
therapy
other
diseases.—Huang,
S.,
Ge,
X.,
Yu,
J.,
Han,
Z.,
Yin,
Li,
Y.,
Chen,
F.,
Wang,
H.,
Zhang,
Lei,
P.
Increased
following
inhibits
contributes
FASEB
J.
32,
512-528
(2018).
www.fasebj.org
ACS Nano,
Journal Year:
2017,
Volume and Issue:
11(11), P. 10883 - 10893
Published: Sept. 29, 2017
Exosomes
are
emerging
as
effective
therapeutic
tools
for
various
pathologies.
These
extracellular
vesicles
can
bypass
biological
barriers,
including
the
blood-brain
barrier,
and
serve
powerful
drug
gene
therapy
transporters.
However,
progress
of
development
is
impeded
by
several
challenges,
insufficient
data
on
exosome
trafficking
biodistribution
difficulty
to
image
deep
brain
structures
in
vivo.
Herein,
we
established
a
method
noninvasive
vivo
neuroimaging
tracking
exosomes,
based
glucose-coated
gold
nanoparticle
(GNP)
labeling
computed
tomography
imaging.
Labeling
exosomes
with
GNPs
was
achieved
directly,
opposed
typical
less
efficient
indirect
mode
through
parent
cells.
On
mechanistic
level,
found
that
were
uptaken
into
MSC-derived
via
an
active,
energy-dependent
mechanism
mediated
glucose
transporter
GLUT-1
involves
endocytic
proteins.
Next,
determined
optimal
parameters
size
administration
route;
demonstrated
5
nm
enabled
improved
intranasal,
compared
intravenous,
led
superior
accumulation
thus
enhanced
neuroimaging.
Furthermore,
using
mouse
model
focal
ischemia,
noninvasively
tracked
intranasally
administered
GNP-labeled
which
showed
increased
at
lesion
site
over
24
h,
nonspecific
migration
clearance
from
control
brains
same
period.
Thus,
this
technique
diagnostic
tool
disorders
could
potentially
enhance
exosome-based
treatments
neuronal
recovery.
Advanced Materials,
Journal Year:
2018,
Volume and Issue:
31(2)
Published: Aug. 20, 2018
Recent
marked
technological
advances
in
the
field
of
exosome
nanotechnology
have
provided
unprecedented
opportunities
to
bloom
developments
exosome-related
biology,
chemistry,
pathology,
and
therapeutics,
which
laid
a
solid
basis
for
scientific
community
design
exosome-based
nanotheranostic
platforms.
The
unique
structural/compositional/morphological
characteristics
exosomes
as
natural
nanocarriers,
well
their
fascinating
physicochemical/biochemical
properties,
underpin
special
physiopathological
roles,
triggered
concept
that
these
cell-derived
nanovesicles
with
intrinsic
biological
functions
can
be
highly
competent
establishment
next-generation
nanomedicine.
Herein,
efforts
are
made
give
comprehensive
overview
on
recent
based
representative
examples
current
state
art
research,
ranging
from
formation,
function,
preparation,
characterization
extensive
nanomedical
applications.
It
is
expected
better
clearer
elucidation
fundamental
principles
advanced
constructing
theranostic
nanoplatforms,
integrating
advantages
endogenous
nanocarriers
methodology
traditional
nanomedicine,
will
help
unlock
innate
powers
nanoplatforms.
The FASEB Journal,
Journal Year:
2016,
Volume and Issue:
30(11), P. 3853 - 3859
Published: Aug. 10, 2016
Efficient
intercellular
transfer
of
RNAs,
proteins,
and
lipids
as
protected
exosomal
cargo
has
been
demonstrated
in
the
CNS,
but
distinct
physiologic
pathologic
roles
have
not
well
defined
for
this
pathway.
The
capacity
to
isolate
immunochemically
human
plasma
neuron-derived
exosomes
(NDEs),
containing
neuronspecific
cargo,
permitted
characterization
CNS-derived
living
humans.
Constituents
amyloid
β-peptide
(Aβ)42-generating
system
now
are
examined
2
sets
neural
cells
by
quantification
astrocyte-derived
(ADEs)
NDEs,
enriched
separately
from
plasmas
patients
with
Alzheimer's
disease
(AD)
or
frontotemporal
dementia
(FTD)
andmatched
cognitively
normal
controls.
ADE
levels
β-site
precursor
protein-cleaving
enzyme
1
(BACE-1),
γ-secretase,
soluble
Aβ42,
protein
(sAPP)β,
sAPPα,
glial-derived
neurotrophic
factor
(GDNF),
P-T181-tau,
P-S396-tau
were
significantly
(3-
20-fold)
higher
than
NDEs
BACE-1
also
a
mean
7-fold
ADEs
cultured
rat
type-specific
cells.
Levels
sAPPβ
GDNF
lower
AD
those
controls,
different
FTD
Abundant
proteins
Aβ42
peptide-generating
may
sustain
neurons.
be
useful
studies
mechanisms
cellular
interactions
effects
inhibitors
AD.—Goetzl,
E.
J.,
Mustapic,
M.,
Kapogiannis,
D.,
Eitan,
E.,
Lobach,
I.
V.,
Goetzl,
L.,
Schwartz,
J.
B.,
Miller,
B.
L.
Cargo
disease.
FASEB
30,
3853–3859
(2016)
www.fasebj.org
Advanced Materials,
Journal Year:
2018,
Volume and Issue:
30(22)
Published: March 26, 2018
Abstract
White
blood
cells
(WBCs)
are
a
major
component
of
immunity
in
response
to
pathogen
invasion.
Neutrophils
the
most
abundant
WBCs
humans,
playing
central
role
acute
inflammation
induced
by
pathogens.
Adhesion
vasculature
and
tissue
infiltration
neutrophils
key
processes
inflammation.
Many
inflammatory/autoimmune
disorders
cancer
therapies
have
been
found
be
involved
activation
neutrophils.
A
promising
strategy
develop
novel
targeted
drug
delivery
systems
is
targeting
exploitation
activated
Herein,
new
platform
based
on
reviewed.
There
two
types
systems:
as
carriers
neutrophil‐membrane‐derived
nanovesicles.
It
discussed
how
nanoparticles
hijack
vivo
deliver
therapeutics
across
vessel
barriers
nanovesicles
target
inflamed
vasculature.
Finally,
potential
applications
neutrophil‐based
treating
cancers
presented.